Bernard B. Brodie Award in Drug Metabolism

Bernard B. Brodie Award in Drug Metabolism. The Bernard B. Brodie Award in Drug Metabolism is a distinguished scientific prize presented by the American Society for Pharmacology and Experimental Therapeutics to honor exceptional achievement in research related to drug metabolism and disposition. Established in 1978, it commemorates the pioneering work of Bernard B. Brodie, a foundational figure in the field of pharmacology and biochemical pharmacology. The award recognizes scientists whose work has profoundly advanced the understanding of how the body processes drugs, a critical area for drug development and personalized medicine.

History and Background

The award was inaugurated in 1978 by the American Society for Pharmacology and Experimental Therapeutics, a leading professional organization founded in 1908. Its creation was a direct tribute to the legacy of Bernard B. Brodie, often called the "father of modern pharmacology." Brodie's transformative research at the National Institutes of Health and other institutions laid the groundwork for the entire discipline of drug metabolism, moving the field from descriptive studies to mechanistic understanding. His development of innovative analytical techniques, such as spectrofluorometry, allowed for the precise measurement of drugs and their metabolites in biological tissues, revolutionizing studies in pharmacokinetics and toxicology. The establishment of this award coincided with a period of rapid growth in the field, spurred by advances in analytical chemistry and molecular biology.

Award Description and Criteria

The Bernard B. Brodie Award is conferred annually to a scientist who has made seminal and sustained contributions to the science of drug metabolism and disposition. The selection criteria emphasize original research that has significantly expanded fundamental knowledge regarding the enzymatic pathways, transport proteins, and genetic polymorphisms that govern the fate of drugs and other xenobiotics in the body. The awardee is typically a senior investigator with an internationally recognized body of work, often involving the characterization of key cytochrome P450 enzymes or other drug-metabolizing enzymes. As part of the honor, the recipient delivers a featured lecture at the annual meeting of the American Society for Pharmacology and Experimental Therapeutics and receives a monetary prize and commemorative plaque.

Notable Recipients

The roster of awardees includes many luminaries who have defined the modern field. Early recipients include foundational researchers like James R. Gillette (1979), a key collaborator of Brodie, and Donald G. McDevitt (1982). The list encompasses scientists who elucidated major metabolic pathways, such as Paul S. Lietman (1980) and John Caldwell (1995). More recent honorees have driven the molecular revolution in the field, including Frank J. Gonzalez (2004) for his work on cytochrome P450 genetics, Kenneth E. Thummel (2011) for research on drug-drug interactions, and Michele A. Evans (2018) for contributions to transporters and pharmacogenomics. Other distinguished recipients are Robert A. Branch (1998), John O. Miners (2014), and Marilyn E. Morris (2020).

Significance and Impact

The award holds substantial prestige within the global pharmacological community, serving as a benchmark for career achievement in drug metabolism. It highlights research that is directly applicable to improving drug safety, optimizing therapeutic efficacy, and understanding inter-individual variability in drug response. Work recognized by the award has directly influenced regulatory science at agencies like the U.S. Food and Drug Administration and underpins critical concepts in clinical pharmacology. By honoring transformative science, the award encourages continued innovation in areas such as pharmacogenomics, preclinical development, and translational research, ensuring the legacy of Bernard B. Brodie's investigative spirit endures.

Administration and Sponsorship

The award is administered by the American Society for Pharmacology and Experimental Therapeutics through its awards committee. For many years, the award was sponsored by the pharmaceutical company Hoffmann–La Roche, providing the monetary stipend and supporting the award lecture. The society manages the nomination process, selection by a peer-review panel, and the presentation ceremony at its annual meeting, often held in conjunction with other events like the Experimental Biology conference. This partnership between a major scientific society and industry underscores the translational importance of fundamental research in drug metabolism for the entire biomedical enterprise. Category:Medical and health awards Category:American Society for Pharmacology and Experimental Therapeutics Category:Pharmacology awards